Virtu Financial LLC Titan Pharmaceuticals Inc Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$0.77 - $22.8 $6,353 - $188,122	-8,251 Reduced 29.12%	20,080 $16,000
Q3 2022 Nov 07, 2022	SELL	$0.53 - $22.6 $18,021 - $768,445	-34,002 Reduced 54.55%	28,331 $31,000
Q2 2022 Aug 09, 2022	BUY	$0.38 - $0.94 $23,686 - $58,593	62,333 New	62,333 $35,000
Q1 2022 May 17, 2022	SELL	$0.89 - $1.26 $13,725 - $19,431	-15,422 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$1.02 - $1.93 $15,730 - $29,764	15,422 New	15,422 $16,000
Q3 2021 Nov 12, 2021	SELL	$1.87 - $2.57 $62,287 - $85,604	-33,309 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$2.24 - $2.9 $74,612 - $96,596	33,309 New	33,309 $87,000

Ticker TTNP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,629,200
Market Cap $58.5M
Description
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the Euro...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.